Fast Track and Modular frameworks facilitate product development continuity via seamless process transfer to the company’s viral vector center of excellence.
Enables Bristol Myers Squibb to expand its manufacturing capacity, meeting the growing demand for its range of cell therapies through Cellares’ platform.
This webinar will cover the key steps and considerations involved in bringing novel nanoparticle-based therapeutics from early R&D to commercial stages.